Effective platelet inhibition by aspirin and clopidogrel: where are we now?

Effective platelet inhibition by aspirin and clopidogrel: where are we now?

Detalhes bibliográficos
Main Authors:	Tousoulis, D, Briasoulis, A, Dhamrait, S, Antoniades, C, Stefanadis, C
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registos relacionados

Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
Por: Antoniades, C, et al.
Publicado em: (2007)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
Por: Wiktor Kuliczkowski, et al.
Publicado em: (2021-01-01)

Where are we now and where are we headed?
Por: Ewan A. Langan
Publicado em: (2023-06-01)

The oxidative stress menace to coronary vasculature: any place for antioxidants?
Por: Briasoulis, A, et al.
Publicado em: (2009)

Progenitor cells and vascular endothelium
Por: Briasoulis, A, et al.
Publicado em: (2011)

Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy
Por: Sarah Shropshire, et al.
Publicado em: (2020-03-01)

Onchodermatitis: Where Are We Now?
Por: Michele E. Murdoch
Publicado em: (2018-09-01)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
Por: Michał P. Wasilewicz, et al.
Publicado em: (2023-04-01)

Tuberculosis elimination: where are we now?
Por: Alberto Matteelli, et al.
Publicado em: (2018-06-01)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
Por: Gordon A. McLorie
Publicado em: (2008-01-01)

Myocardial T1 mapping: where are we now and where are we going?
Por: Abdel-Gadir A, et al.
Publicado em: (2014-11-01)

Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery.
Por: Yannick Le Manach, et al.
Publicado em: (2014-01-01)

Heart regeneration: what cells to use and how?
Por: Tousoulis, D, et al.
Publicado em: (2008)

The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
Por: Briasoulis, A, et al.
Publicado em: (2011)

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.
Por: Tousoulis, D, et al.
Publicado em: (2008)

The failure of immunomodulation therapy in heart failure: does the statins "paradigm" prove the rule?
Por: Tousoulis, D, et al.
Publicado em: (2010)

Aspirin versus clopidogrel: the wrong question?
Por: Born, G, et al.
Publicado em: (1997)

CAR-T cell therapy: Where are we now, and where are we heading?
Por: Jia-Yi Wang, et al.
Publicado em: (2023-10-01)

Targeting therapy in pemphigus: Where are we now and where are we going?
Por: Kailibinuer Abulikemu, et al.
Publicado em: (2023-06-01)

On Taxation of the Digital Economy. Where Are We Now and Where Are We Going?
Por: Alin IRIMIA, et al.
Publicado em: (2021-11-01)

Where we live now [kasetvideo]
Publicado em: (1979)

Microbiota and Obesity: Where Are We Now?
Por: Andrea Ballini, et al.
Publicado em: (2020-11-01)

Cannabinoids in Periodontology: Where Are We Now?
Por: Yésica Carmona Rendón, et al.
Publicado em: (2023-11-01)

Crop Improvement: Where Are We Now?
Por: Pierre Sourdille, et al.
Publicado em: (2022-09-01)

Epilepsy and psychosis– where are we now?
Por: I. Pereira, et al.
Publicado em: (2021-04-01)

Genetics of migraine: where are we now?
Por: Lou Grangeon, et al.
Publicado em: (2023-02-01)

Osteochondral techniques: where are we now?
Por: Giovanna Medina, et al.
Publicado em: (2023-03-01)

Editorial: This Is Where We Dance Now
Por: Harmony Bench, et al.
Publicado em: (2021-07-01)

Security training: where are we now?
Por: Koenraad Van Brabant
Publicado em: (1999-04-01)

Depression research: where are we now?
Por: Lee Saebom, et al.
Publicado em: (2010-03-01)

Intracranial Atherosclerosis: Where Are We Now?
Por: Jong S. Kim
Publicado em: (2017-09-01)

Advances in digital CBT: where are we now, and where next?
Por: Thew, G, et al.
Publicado em: (2022)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
Por: Hemlata, et al.
Publicado em: (2013-01-01)

Where we have been, where we are now, and where we might be heading : Where next for the coaching relationship?
Por: Alanna O'Broin
Publicado em: (2016-12-01)

Etomidate in pediatric anesthesiology: Where are we now?
Por: Joseph D Tobias
Publicado em: (2015-01-01)

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
Por: Tousoulis, D, et al.
Publicado em: (2008)

Editorial: Where Are We Now and Where Do We Go From Here
Por: Gabriele Manganaro
Publicado em: (2022-01-01)

Yellow fever control in Cameroon: Where are we now and where are we going?
Por: Mimbouga Julienne, et al.
Publicado em: (2008-02-01)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
Por: MOHAMED H AHMED
Publicado em: (2018-07-01)

Pharmacological Therapy for COVID-19: Where Are We Now and Where Are We Going?
Por: Baha Eldin Hassan Juma, et al.
Publicado em: (2020-04-01)